Healthcare Infection Control Practices Advisory Committee, (HICPAC)

---
identifier: "/us/fr/E9-25913"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Healthcare Infection Control Practices Advisory Committee, (HICPAC)"
title_number: 0
title_name: "Federal Register"
section_number: "E9-25913"
section_name: "Healthcare Infection Control Practices Advisory Committee, (HICPAC)"
positive_law: false
currency: "2009-10-28"
last_updated: "2009-10-28"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-25913"
document_type: "notice"
publication_date: "2009-10-28"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "74 FR 55567"
fr_volume: 74
---


#  Healthcare Infection Control Practices Advisory Committee, (HICPAC)

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee:

*Times and Dates:* 9 a.m.-5 p.m., November 12, 2009. 9 a.m.-12 p.m., November 13, 2009.

*Place:* Washington Marriott at Metro Center, Salons C-D, 775 12th Street, NW., Washington, DC 20005, Telephone: (202) 737-2200.

*Status:* Open to the public, limited only by the space available.

*Purpose:* The Committee is charged with providing advice and guidance to the Secretary, HHS; the Assistant Secretary for Health, HHS; the Director, CDC; and the Director, National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections ( *e.g.* , nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.

*Matters To Be Discussed:* The agenda will include updates on Recovery Act activities and the draft guideline for prevention of intravascular catheter-related bloodstream infections, and discussion of infection control in ambulatory care settings.

Agenda items are subject to change as priorities dictate.

*Contact Person For More Information:* Michelle King, HICPAC, Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton Road, NE., Mailstop A-07, Atlanta, Georgia 30333 Telephone (404) 639-2936.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: October 20, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.